The FDA and DEA are warning patients to toss drugs purchased from two unregistered pharmacies accused of illegally selling Adderall online.
Kubapharm.com and Premiumlightssupplier.com were both accused of selling amphetamine drugs marketed as the ADHD drug Adderall without a prescription, according to an FDA statement on Tuesday. The agency also claims the pharmacies (which failed to register with the DEA) sold the medication without the proper labeling.
As Adderall has a high abuse potential and “should only be used under the supervision of a licensed healthcare professional,” the FDA requires the medication to be sold with a black box warning outlining the risks.
So far in 2022, the FDA has issued six warning letters to various online pharmacies for the unlawful sale of drugs over the internet. However, these two warnings were specifically for the sale of Schedule II drugs — drugs designated by the DEA to have high potential for abuse. Adderall abuse, especially among students and young adults, has been a widespread issue for the past two decades.
As a result of the Covid-19 pandemic, online pharmacies grew substantially, and rogue pharmacies followed. These illegitimate pharmacies exploited customers by selling purported Covid-19 treatments among other medications.
Outside of Adderall, both sites claim to sell various other drugs, including anxiety medication Xanax. Consumers should toss any medications purchased from these sites, the FDA said.
“The illegal sale of prescription drug stimulants online puts Americans at risk and contributes to potential abuse, misuse and overdose,” FDA Commissioner Robert Califf said in the press release. “These particular types of online pharmacies also undermine our efforts to help consumers safely purchase legitimate prescription medicines over the internet.”
The letters were issued on March 30, and according to the FDA, the websites will have 15 days to respond with specific steps for addressing their violations.